Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Effect of Open Tray Versus Digital Impressions on the Passivity and Prosthetic Complications of Full Arch Screw-retained Prosthesis

13 de abril de 2021 actualizado por: Shymaa Hassan Hussein Mohamed Elsharkawy, Cairo University

Effect of Open Tray Versus Digital Impressions on the Passivity and Prosthetic Complications of Full Arch Screw-retained Prosthesis - A Randomized Control Trial Study

The importance of this trial lies in testing if intraoral digital impressions will increase the accuracy of impressions of full arch implant cases over conventional impression techniques thus improving the passivity of full arch screw retained prosthesis and decreasing the prosthetic complications in turn.

Descripción general del estudio

Descripción detallada

In this study intraoral digital impressions will be used for scanning full arch implant cases to minimize the variables in the conventional technique, finally the study will investigate if the intraoral digital impressions will increase the accuracy of impressions of full arch implant cases thus improving the passivity and decreasing prosthetic complications of screw retained prosthesis for a long-term success compared to open tray impression technique.

Primary outcome will be evaluation of the passivity of PMMA (Polymethyl methacrylate ) try-in , while secondary outcomes will be detecting prosthetic complications (screw loosening , prosthesis fracture) and treatment time for both groups.

Eligibility criteria:

Inclusion criteria:

  • Completely edentulous patients with sufficient inter-arch space to receive fixed prosthesis (Crown height space 9-15 mm per arch)
  • Completely edentulous patients with 4 implants in mandible and/ or 6 implants in maxilla
  • sufficient bone volume for implant placement without graft a confirmed by CBCT
  • adequate zone of keratinized mucosa ( > 2mm width)
  • All genders
  • Acceptable oral hygiene
  • Cooperative patients
  • Controlled systemic diseases ( Diabetes, hypertension)

Exclusion criteria:

  • Completely edentulous patients with insufficient inter-arch space to receive fixed prosthesis ( Crown height space lesser than 9mm per arch)
  • Insufficient bone volume for implant placement
  • Completely edentulous patients with in-adequate zone of keratinized mucosa (< 2mm).
  • Un cooperative patients
  • Poor oral hygiene
  • Uncontrolled diabetic patients( Diabetes, hypertension)

Interventions:

Completely edentulous patients that have received dental implants and ready to start prosthetic steps of full arch screw retained prosthesis will be recruited and randomly divided into two groups.

Group 1 ( control group):

  • Primary impression will be taken followed by customization of open special trays for each patient.
  • Transfer copings will be screwed to the multiunit abutments on the existing implants, and splinted together using pre-cured printed resin splinting framework that will be fixed to the copings using flowable composite and one step impression technique using putty and light addition silicon will be made . Implant analogs will be attached to the transfer copings and pouring of the impression will be done using dental stone.
  • Bite registration will be done followed by mounting of stone casts on the articulator.
  • Patient's stone models and bite will be scanned using desktop scanner and the trial PMMA bridge will be designed and 3D-printed as a verification jig to evaluate the accuracy of the taken impression.
  • Passivity of the trial PMMA bridge will be evaluated on patients intra-orally using single screw test, peri-apical radiographs and Screw resistance parameter (SR parameter).
  • Regarding the final prosthesis a framework will be designed on the patient's scan and milled from (PEEK blocks) , finished and polished then layered by (pink composite ) and (composite teeth) will be used.
  • Final prosthesis will be delivered to the patient and treatment time will be measured by the number of visits starting from impression taking session till delivery session.
  • Follow up of the patients will be done every at 3 and 6 months to check if there are any prosthetic complications (screw loosening or fracture).

while in Group 2 ( intervention group):

  • Intra-oral scanner will be used in the study to take a digital impression for the implants.
  • 3D printed generic Scan bodies with unified shape and length replacing the traditional transfer copings will be press fitted on the trans-mucosal abutments and pickup cylinders that are screwed on the implants to capture their position and intra-oral scanning will be done.
  • With scan bodies in place, bite will be registered where, in case of completely edentulous upper and lower arches a 3D printed centric holding device will be used to fix the vertical dimension at the desired height and the intra-oral scanner will capture the bite at this position, but in case of a completely edentulous arch opposed by dentulous arch , a green stick jig will be customized anteriorly to hold vertical dimension at the desired height and intra-oral scanner will be used to record the bite bilaterally.
  • The STL file of the captured scan will be 3D-printed into a resin model with negative places replicating the analogues design in which the digital analogues will be seated.
  • The trial PMMA bridge will be designed on the implants scan then 3D- printed, to be fitted on the resin model having digital analogues in place.
  • Passivity of the trial PMMA bridge will be evaluated on patients the same way as group 1.
  • The final prosthesis a framework will be designed and milled as in group 1 then delivered to the patient outcomes:
  • Passivity of PMMA tryin: will be measured by Single screw test, Periapical radiograph, Screw resistance parameter (SR parameter) at PMMA tryin visit (2nd visit after impressions Instantly).
  • Prosthetic complications (screw loosening , prosthesis fracture) : will be measured by Clinical examination at 3, 6 months of delivery of final prosthesis.
  • Treatment time : will be measured by Number of visits at the last visit.

Tipo de estudio

Intervencionista

Inscripción (Anticipado)

92

Fase

  • No aplica

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Niño
  • Adulto
  • Adulto Mayor

Acepta Voluntarios Saludables

Sí

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Completely edentulous patients with sufficient inter-arch space to receive fixed prosthesis (Crown height space 9-15 mm per arch)
  • Completely edentulous patients with 4 implants in mandible and/ or 6 implants in maxilla
  • sufficient bone volume for implant placement without graft a confirmed by CBCT
  • adequate zone of keratinized mucosa ( > 2mm width)
  • All genders
  • Acceptable oral hygiene
  • Cooperative patients
  • Controlled systemic diseases ( Diabetes, hypertension)

Exclusion Criteria:

  • Completely edentulous patients with sufficient inter-arch space to receive fixed prosthesis (Crown height space 9-15 mm per arch)

    • Completely edentulous patients with 4 implants in mandible and/ or 6 implants in maxilla
    • sufficient bone volume for implant placement without graft a confirmed by CBCT
    • adequate zone of keratinized mucosa ( > 2mm width)
    • All genders
    • Acceptable oral hygiene
    • Cooperative patients
    • Controlled systemic diseases ( Diabetes, hypertension)

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Doble

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Otro: Digital impression technique
- 3D printed generic Scan bodies with unified shape and length replacing the traditional transfer copings will be press fitted on the trans-mucosal abutments and pickup cylinders that are screwed on the implants to capture their position and intra-oral scanning will be done.
3D printed generic Scan bodies with unified shape and length replacing the traditional transfer copings will be press fitted on the trans-mucosal abutments and pickup cylinders that are screwed on the implants to capture their position and intra-oral scanning will be done.
Otro: Open tray impression technique
  • Transfer copings will be screwed to the multiunit abutments on the existing implants, and splinted together using pre-cured printed resin splinting framework that will be fixed to the copings using flowable composite .
  • A one step impression technique using putty and light addition silicon will be made, where light impression material will be injected all around transfer copings and putty silicon will be loaded in tray and then will be seated intra-orally making sure to fully expose the screws of transfer copings through the impression material.

Transfer copings will be screwed to the multiunit abutments on the existing implants, and splinted together using pre-cured printed resin splinting framework that will be fixed to the copings using flowable composite .

A one step impression technique using putty and light addition silicon will be made, where light impression material will be injected all around transfer copings and putty silicon will be loaded in tray and then will be seated intra-orally making sure to fully expose the screws of transfer copings through the impression material.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Passivity of seating of PolyMethylMethAcrylate (PMMA) tryin prosthesis
Periodo de tiempo: 3-4 months after implants placement after final impressions for implants
the screw retained prosthesis can be considered passive when it does not generate static loads and strains within the prosthesis or in the surrounding bone structure measured using Single screw test (measuring unit : binary - yes/No)
3-4 months after implants placement after final impressions for implants
Passivity of seating of PolyMethylMethAcrylate (PMMA) tryin prosthesis
Periodo de tiempo: 3-4 months after implants placement after final impressions for implants

the screw retained prosthesis can be considered passive when it does not generate static loads and strains within the prosthesis or in the surrounding bone structure measured using

-Periapical radiograph ( measuring unit : binary- Yes/No)

3-4 months after implants placement after final impressions for implants
Passivity of seating of PolyMethylMethAcrylate (PMMA) tryin prosthesis
Periodo de tiempo: 3-4 months after implants placement after final impressions for implants

the screw retained prosthesis can be considered passive when it does not generate static loads and strains within the prosthesis or in the surrounding bone structure measured using

- Screw resistance parameter (Measuring unit: Difference of rotation angles in passive and non- passive situations)

3-4 months after implants placement after final impressions for implants

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Prosthetic complications including screw loosening and prosthesis fracture
Periodo de tiempo: At 3, 6 months after delivery of final prosthesis
screw loosening , prosthesis fracture will be assessed by clinical examination (measuring unit : number of times )
At 3, 6 months after delivery of final prosthesis
Treatment time
Periodo de tiempo: 5-6 months after implants placement ( at the last visit )
Number of visits
5-6 months after implants placement ( at the last visit )

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Anticipado)

1 de junio de 2021

Finalización primaria (Anticipado)

1 de diciembre de 2022

Finalización del estudio (Anticipado)

1 de diciembre de 2022

Fechas de registro del estudio

Enviado por primera vez

6 de abril de 2021

Primero enviado que cumplió con los criterios de control de calidad

13 de abril de 2021

Publicado por primera vez (Actual)

19 de abril de 2021

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

19 de abril de 2021

Última actualización enviada que cumplió con los criterios de control de calidad

13 de abril de 2021

Última verificación

1 de abril de 2021

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • PRO 6-2-2

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

producto fabricado y exportado desde los EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir